References 388% CONFIDENCEOverall confidence: 88%How well the pin's source and references back up its dates.Weighted average of how firmly 3 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better
The first entry is always the pin's source. Overall confidence is a weighted average of how firmly each reference supports the start and end times used above; a reference counts half as much for every 180 days older than the newest.
- [1]90%abbott.mediaroom.com/2026-08-27-Abbotts-next-generation-Amulet-360-TM-device-receives-CE-Mark-to-treat-people-with-atrial-fibrillation-at-risk-of-strokeabbott.mediaroom.com· Posted Sep 23, 2026· Starts Aug 27, 2026 ✓· 43% of score
The release is datelined "ABBOTT PARK, Ill., Aug. 27, 2026" and says Abbott "announced today it has received CE Mark for the Amulet 360 Left Atrial Appendage (LAA) Occluder".
- [2]85%Abbott wins CE mark for new LAA closure devicemedtechdive.com· Published Aug 28, 2026· 39% of score
MedTech Dive's report of the CE Mark with the market context (Boston Scientific's share, Ford's $2 billion market figure) and the May FDA submission.
- [3]88%Early Outcomes With a Next-Generation Dual-Seal Left Atrial Appendage Occluder: Results From the VERITAS Study (JACC: Clinical Electrophysiology)doi.org· Published Feb 6, 2026· 18% of score
The peer-reviewed VERITAS 45-day results that the release says supported the CE Mark: 400 patients, 99.8% implant success, 93.9% complete closure.[1]
Suggest a correction
Something missing or wrong? Say it in your own words: a link that backs this pin up, a different start or end date and why, or a fact it lacks or gets wrong. The AI checks it against this pin's sources, searches for better ones, and adds any page that backs you up. The pin's own sources still count most. A picture that shows something else, or shows it badly, is looked at too, and moved down or replaced.